DiaMedica Therapeutics Inc — Quarterly Cash Flow (NASDAQ:DMAC) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 52.52 M46.34 M38.83 M31.47 M57.05 M Total liabilities 4.56 M5.63 M4.88 M4.3 M5.42 M Total equity 48 M40.7 M34 M27.2 M51.6 M Total liabilities & shareholders' equities 52.52 M46.34 M38.83 M31.47 M57.05 M Total debt ————— Net debt —————

新闻

Cantor Fitzgerald重申DiaMedica股票"增持"评级

Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock

DiaMedica将为子痫前期治疗进行额外研究

DiaMedica to conduct additional study for preeclampsia treatment

Cisco, Flutter, Manulife and more set to report earnings Wednesday

TD Cowen给DiaMedica Therapeutics股票首次评级为"买入"

DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen

Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update

DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?

After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade

What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?